Metagenomi, Inc.
MGX
$1.86
-$0.05-2.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.12M | -77.95M | -78.06M | -73.95M | -75.00M |
| Total Depreciation and Amortization | 5.52M | 5.49M | 5.41M | 5.15M | 4.94M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.82M | 21.43M | 23.25M | 14.00M | 12.56M |
| Change in Net Operating Assets | -38.22M | -51.04M | -59.67M | -48.59M | -42.98M |
| Cash from Operations | -97.01M | -102.07M | -109.07M | -103.39M | -100.48M |
| Capital Expenditure | -1.95M | -2.49M | -3.11M | -4.52M | -5.58M |
| Sale of Property, Plant, and Equipment | 37.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.32M | 33.79M | -85.04M | -51.55M | 34.33M |
| Cash from Investing | 63.41M | 31.30M | -88.16M | -56.07M | 28.75M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 109.00K | 0.00 | 86.54M | 86.54M | 86.54M |
| Repurchase of Common Stock | -492.00K | -2.52M | -2.52M | -2.52M | -2.03M |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -352.00K | -77.00K | -- | -1.33M | -3.24M |
| Cash from Financing | -735.00K | -2.60M | 84.01M | 82.68M | 81.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.33M | -73.36M | -113.22M | -76.78M | 9.53M |